[Business Wire] – Supernus Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, today announced that the Company expects to report fourth quart moreView todays social media effects on SUPNView the latest stocks trending across Twitter. Click to view dashboardSee who Supernus is hiring next, click here to […]
[Business Wire] – Supernus Pharmaceuticals, Inc. , a specialty pharmaceutical company, today announced that the Company’s management will provide a business update on the Company at th moreView todays social media effects on SUPNView the latest stocks trending across Twitter. Click to view dashboardSee who Supernus is hiring next, click here to view […]
[at noodls] – ROCKVILLE, Md., Feb. 1, 2013 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq:SUPN), a specialty pharmaceutical company, today announced that Oxtellar XR tablets are now available for sale in … moreView todays social media effects on SUPNView the latest stocks trending across Twitter. Click to view dashboardSee who Supernus is hiring next, click here to view […]
[at noodls] – ROCKVILLE, Md., Jan. 14, 2013 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq:SUPN), a specialty pharmaceutical company, today announced the appointment of Victor Vaughn to the position of Senior … moreView todays social media effects on SUPNView the latest stocks trending across Twitter. Click to view dashboardSee who Supernus is hiring next, click here to view […]
[at noodls] – ROCKVILLE, Md., Nov. 29, 2012 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq:SUPN), a specialty pharmaceutical company announced the pricing of the underwritten public offering of 6,000,000 … moreView todays social media effects on SUPNView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – ROCKVILLE, Md., Nov. 20, 2012 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq:SUPN), a specialty pharmaceutical company, received positive topline results from its Phase IIb study on SPN-810 … moreView todays social media effects on SUPNView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – ROCKVILLE, Md., Nov. 19, 2012 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq:SUPN), a specialty pharmaceutical company, announced today that it has received confirmation from the Food and Drug … moreView todays social media effects on SUPNView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – ROCKVILLE, Md., Nov. 7, 2012 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq:SUPN), a specialty pharmaceutical company, reported in the November 2, 2012 filing of the Form 10-Q consolidated … moreView todays social media effects on SUPNView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – ROCKVILLE, Md., Oct. 31, 2012 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq:SUPN), a specialty pharmaceutical company, announced today that Michael Sheffery, a General Partner at OrbiMed Advisors, … moreView todays social media effects on SUPNView the latest stocks trending across Twitter. Click to view dashboard […]
